Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 22, 2022 - Issue 4
Submit an article Journal homepage
3,744
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study

Marco Galluzzoa Dermatology Unit, Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3424-5175View further author information
ORCID Icon,
Marina Talamontia Dermatology Unit, Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, ItalyORCID Iconhttps://orcid.org/0000-0002-3070-4071View further author information
ORCID Icon,
Laura Atzorib Section of Dermatology, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, ItalyORCID Iconhttps://orcid.org/0000-0002-8105-1402View further author information
ORCID Icon,
Federico Bardazzic Dermatology Division, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, ItalyView further author information
,
Anna Campanatid Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of the Marche Region, Ancona, ItalyORCID Iconhttps://orcid.org/0000-0002-3740-0839View further author information
ORCID Icon,
Antonella Di Cesaree Dermatology Clinic, Department of Health Sciences, University of Florence, Florence, ItalyView further author information
,
Federico Diotallevid Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of the Marche Region, Ancona, ItalyView further author information
,
Maria Laura Florif Dermatology Section, Department of Medical, Surgical and Neurological Science, University of Siena, S. Maria Alle Scotte Hospital, Siena, ItalyView further author information
,
Cristina Mugheddub Section of Dermatology, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, ItalyView further author information
,
Annamaria Offidanid Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of the Marche Region, Ancona, ItalyView further author information
,
Stefano Piasericog Dermatology Unit - Department of Medicine, University of Padova, Padova, ItalyView further author information
,
Filomena Russof Dermatology Section, Department of Medical, Surgical and Neurological Science, University of Siena, S. Maria Alle Scotte Hospital, Siena, ItalyView further author information
,
Lidia Sacchellic Dermatology Division, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, ItalyORCID Iconhttps://orcid.org/0000-0003-4388-4523View further author information
ORCID Icon,
Luca Bianchia Dermatology Unit, Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, ItalyORCID Iconhttps://orcid.org/0000-0001-8697-6896View further author information
ORCID Icon &
Francesca Prignanoe Dermatology Clinic, Department of Health Sciences, University of Florence, Florence, ItalyView further author information
 show all
Pages 547-554 | Received 23 Dec 2021, Accepted 12 Jan 2022, Published online: 20 Jan 2022

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Luca Mastorino, Lorenza Burzi, Giada Frigatti, Alessandra Fazio, Valentina Celoria, Nicole Macagno, Francois Rosset, Stefania Ginevra Passerini, Gabriele Roccuzzo, Anna Verrone, Elena Stroppiana, Michela Ortoncelli, Paolo Dapavo, Pietro Quaglino & Simone Ribero. (2023) Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life study. Expert Opinion on Biological Therapy 23:9, pages 929-936.
Read now

Articles from other publishers (2)

Vishnu Eshwar, Ashwin Kamath, Rajeshwari Shastry, Ashok K. Shenoy & Priyanka Kamath. (2022) A Review of the Safety of Interleukin-17A Inhibitor Secukinumab. Pharmaceuticals 15:11, pages 1365.
Crossref
Marco Galluzzo, Marina Talamonti, Arnaldo Cioni, Virginia Maffei, Ruslana Gaeta Shumak, Lorenzo Tofani, Luca Bianchi & Elena Campione. (2022) Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital Psoriasis. Journal of Clinical Medicine 11:9, pages 2631.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.